Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by Pocketsundialon Jan 03, 2018 12:45am

142 Views

Post# 27267967

Terps vs Greenhouses - New age change up

Terpene provider for we are kured (Ebnya) appears to be a Jewish company. Israel is known around the world for its scientific gains in the Cannabis world. When the greenhouses clearly are not cutting it, it's a good sign to see a decent backup plan begin to take shape. When the going gets tough, you either find something that works or get EFF out We were at 10 cents with greenhouses and touched the .40,s on news of a game change up into the CBD market/vape/terp. Supports good, don't sell cheap. Build some better greenhouses for the future...?

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features